Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Наружные средства, содержащие ретинальдегид, в комплексной терапии больных с поздними акне
Наружные средства, содержащие ретинальдегид, в комплексной терапии больных с поздними акне
Пашинян А.Г. Наружные средства, содержащие ретинальдегид, в комплексной терапии больных с поздними акне. Consilium Medicum. Дерматология (Прил.). 2016; 2: 40–43.
________________________________________________
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Аннотация
Представлены данные, подтверждающие клиническую эффективность эмульсии TriAcneal Expert («Пьер Фабр», Франция) у пациентов с акне легкой степени тяжести, которая применяется в составе медикаментозной терапии при среднетяжелом акне. Применение TriAcneal Expert способствует быстрому купированию симптомов постакне. Были проанализированы объективные и субъективные данные о переносимости, эффективности и безопасности эмульсии TriAcneal Expert.
________________________________________________
Полный текст
Список литературы
1. Ballanger F, Baudry P, N'Guyen JM et al. Heredity: a prognostic factor for acne. Dermatology 2006; 212 (2): 145–9.
2. Williams HC, Dellavalle RP, Garner S. Acne vulgaris. Lancet 2011; 379: 361–72.
3. Kircik LH. Advances in the Understanding of the Pathogenesis of Inflammatory Acne. J Drugs Dermatol 2016; 15 (1): 7–10.
4. Makrantonaki E, Ganceviciene R, Zouboulis C. An update on the role of the sebaceous gland in the pathogenesis of acne. Dermatoendocrinol 2011; 3 (1): 41–49. Doi:10.4161.
5. Kircik LH. Advances in the Understanding of the Pathogenesis of Inflammatory Acne. J Drugs Dermatol 2016; 15 (1): 7–10.
6. Arora MK, Yadav A, Saini V. Role of hormones in acne vulgaris. Clin Biochem 2011; 44 (13): 1035–40.
7. Da Cunha MG, Fonseca FLA, Machado CDAS. Androgenic hormone profile of adult women with acne. Dermatology 2013; 226 (2): 167–71. Doi: 10.1159/000347196.
8. Del Prete M, Mauriello MC, Faggiano A et al. Insulin resistance and acne: a new risk factor for men? Endocrine 2012; 42: 555–60.
9. Pace JL. Acne – a potential skin marker of internal disease. Clin Dermatol 2015; 33 (5): 572–8. Doi: 10.1016.
10. Perry A, Lambert P. Propionibacterium acnes: Infection beyond the skin. Exp Rev Anti-infective Ther 2011; 9 (12): 1149–56.
11. Collier CN, Harper JC, Cafardi JA et al. The prevalence of acne in adults 20 years and older. J Am Acad Dermatol 2008; 58: 56–9.
12. Dréno B, Layton A, Zouboulis CC et al. Adult female acne: a new paradigm. J Eur Acad Dermatol Venereol 2013; 27: 1063–70.
13. Choi CW, Lee DH, Kim HS et al. The clinical features of late onset acne compared with early onset acne in women. J Eur Acad Dermatol Venereol 2011; 25 (4): 454–61. Doi: 10.1111/j.1468-3083.2010.03813.
14. Bahali AG, Bahali K, Biyik OD et al. The associations between peer victimization, psychological symptoms and quality of life in adolescents with acne vulgaris. J Eur Acad Dermatol Venereol 2015. Doi: 10.1111/jdv.13495.
15. Акне. Клинические рекомендации. Российское общество дерматовенерологов. Под ред. А.А.Кубановой. М.: ДЭКС-Пресс, 2015. / Akne. Klinicheskie rekomendatsii. Rossiiskoe obshchestvo dermatovenerologov. Pod red. A.A.Kubanovoi. M.: DEKS-Press, 2015. [in Russian]
16. Lynn DD, Umari T, Dunnick CA, Dellavalle RP. The epidemiology of acne vulgaris in late adolescence. Adolesc Health Med Ther 2016; 7: 13–25. Doi: 10.2147/AHMT.S55832.
17. Dréno B, Nocera T, Verrière F et al. Topical retinaldehyde with glycolic acid: study of tolerance and acceptability in association with anti-acne treatments in 1,709 patients. Dermatology 2005; 210 (1): 22–9.
18. Dréno B, Katsambas A, Pelfini C et al. Combined 0.1% retinaldehyde/6% glycolic acid cream in prophylaxis and treatment of acne scarring. Dermatology 2007; 214 (3): 260–7.
19. Dréno B, Castell A, Tsankov N et al. Interest of the association retinaldehyde/glycolic acid in adult acne. J Eur Acad Dermatol Venereol 2009; 23 (5): 529–32. Doi: 10.1111/j.1468-3083.2009.03099.
20. Dréno B, Jean-Decoster C, Georgescu V. Profile of patients with mild to moderate acne in Europe: a survey. Eur J Dermatol 2016; 1.
21. Masini F, Ricci F, Fossati B et al. Combination therapy with retinaldehyde (0.1%) glycolic acid (6%) and efectiose (0.1%) in mild to moderate acne vulgaris during the period of sun exposure – efficacy and skin tolerability. Eur Rev Med Pharmacol Sci 2014; 18 (16): 2283–6.
22. Boisnic S, Branchet-Gumila MC, Segard C. Inhibitory effect of Avene spring water on vasoactive intestinal peptide-induced inflammation in surviving human skin. Int
J Tissue React 2001; 23 (3): 89–95.
23. Merial-Kieny C, Castex-Rizzi N, Selas B et al. Avene Thermal Spring Water: an active component with specific properties. J Eur Acad Dermatol Venereol 2011; 25 (1): 2–5.
24. Poli F, Ribet V, Lauze C et al. Efficacy and safety of 0.1% retinaldehyde/ 6% glycolic acid (diacneal) for mild to moderate acne vulgaris. A multicentre, double-blind, randomized, vehicle-controlled trial. Dermatology 2005; 210 (1): 14–21.
25. Tran C, Kasraee B, Grand D, Carraux P et al. Pharmacology of RALGA, a mixture of retinaldehyde and glycolic acid. Dermatology 2005; 210 (1): 6–13.
26. Wurzbacher H. Occupational medicine examinations of workers exposed to octanediols. Z Gesamte Hyg 1983; 29 (5): 272–3.
27. Dréno B, Tan J, Kang S et al. How People with Facial Acne Scars are Perceived in Society: an Online Survey. Dermatol Ther (Heidelb) 2016; 18.
2. Williams HC, Dellavalle RP, Garner S. Acne vulgaris. Lancet 2011; 379: 361–72.
3. Kircik LH. Advances in the Understanding of the Pathogenesis of Inflammatory Acne. J Drugs Dermatol 2016; 15 (1): 7–10.
4. Makrantonaki E, Ganceviciene R, Zouboulis C. An update on the role of the sebaceous gland in the pathogenesis of acne. Dermatoendocrinol 2011; 3 (1): 41–49. Doi:10.4161.
5. Kircik LH. Advances in the Understanding of the Pathogenesis of Inflammatory Acne. J Drugs Dermatol 2016; 15 (1): 7–10.
6. Arora MK, Yadav A, Saini V. Role of hormones in acne vulgaris. Clin Biochem 2011; 44 (13): 1035–40.
7. Da Cunha MG, Fonseca FLA, Machado CDAS. Androgenic hormone profile of adult women with acne. Dermatology 2013; 226 (2): 167–71. Doi: 10.1159/000347196.
8. Del Prete M, Mauriello MC, Faggiano A et al. Insulin resistance and acne: a new risk factor for men? Endocrine 2012; 42: 555–60.
9. Pace JL. Acne – a potential skin marker of internal disease. Clin Dermatol 2015; 33 (5): 572–8. Doi: 10.1016.
10. Perry A, Lambert P. Propionibacterium acnes: Infection beyond the skin. Exp Rev Anti-infective Ther 2011; 9 (12): 1149–56.
11. Collier CN, Harper JC, Cafardi JA et al. The prevalence of acne in adults 20 years and older. J Am Acad Dermatol 2008; 58: 56–9.
12. Dréno B, Layton A, Zouboulis CC et al. Adult female acne: a new paradigm. J Eur Acad Dermatol Venereol 2013; 27: 1063–70.
13. Choi CW, Lee DH, Kim HS et al. The clinical features of late onset acne compared with early onset acne in women. J Eur Acad Dermatol Venereol 2011; 25 (4): 454–61. Doi: 10.1111/j.1468-3083.2010.03813.
14. Bahali AG, Bahali K, Biyik OD et al. The associations between peer victimization, psychological symptoms and quality of life in adolescents with acne vulgaris. J Eur Acad Dermatol Venereol 2015. Doi: 10.1111/jdv.13495.
15. Akne. Klinicheskie rekomendatsii. Rossiiskoe obshchestvo dermatovenerologov. Pod red. A.A.Kubanovoi. M.: DEKS-Press, 2015. [in Russian]
16. Lynn DD, Umari T, Dunnick CA, Dellavalle RP. The epidemiology of acne vulgaris in late adolescence. Adolesc Health Med Ther 2016; 7: 13–25. Doi: 10.2147/AHMT.S55832.
17. Dréno B, Nocera T, Verrière F et al. Topical retinaldehyde with glycolic acid: study of tolerance and acceptability in association with anti-acne treatments in 1,709 patients. Dermatology 2005; 210 (1): 22–9.
18. Dréno B, Katsambas A, Pelfini C et al. Combined 0.1% retinaldehyde/6% glycolic acid cream in prophylaxis and treatment of acne scarring. Dermatology 2007; 214 (3): 260–7.
19. Dréno B, Castell A, Tsankov N et al. Interest of the association retinaldehyde/glycolic acid in adult acne. J Eur Acad Dermatol Venereol 2009; 23 (5): 529–32. Doi: 10.1111/j.1468-3083.2009.03099.
20. Dréno B, Jean-Decoster C, Georgescu V. Profile of patients with mild to moderate acne in Europe: a survey. Eur J Dermatol 2016; 1.
21. Masini F, Ricci F, Fossati B et al. Combination therapy with retinaldehyde (0.1%) glycolic acid (6%) and efectiose (0.1%) in mild to moderate acne vulgaris during the period of sun exposure – efficacy and skin tolerability. Eur Rev Med Pharmacol Sci 2014; 18 (16): 2283–6.
22. Boisnic S, Branchet-Gumila MC, Segard C. Inhibitory effect of Avene spring water on vasoactive intestinal peptide-induced inflammation in surviving human skin. Int
J Tissue React 2001; 23 (3): 89–95.
23. Merial-Kieny C, Castex-Rizzi N, Selas B et al. Avene Thermal Spring Water: an active component with specific properties. J Eur Acad Dermatol Venereol 2011; 25 (1): 2–5.
24. Poli F, Ribet V, Lauze C et al. Efficacy and safety of 0.1% retinaldehyde/ 6% glycolic acid (diacneal) for mild to moderate acne vulgaris. A multicentre, double-blind, randomized, vehicle-controlled trial. Dermatology 2005; 210 (1): 14–21.
25. Tran C, Kasraee B, Grand D, Carraux P et al. Pharmacology of RALGA, a mixture of retinaldehyde and glycolic acid. Dermatology 2005; 210 (1): 6–13.
26. Wurzbacher H. Occupational medicine examinations of workers exposed to octanediols. Z Gesamte Hyg 1983; 29 (5): 272–3.
27. Dréno B, Tan J, Kang S et al. How People with Facial Acne Scars are Perceived in Society: an Online Survey. Dermatol Ther (Heidelb) 2016; 18.
2. Williams HC, Dellavalle RP, Garner S. Acne vulgaris. Lancet 2011; 379: 361–72.
3. Kircik LH. Advances in the Understanding of the Pathogenesis of Inflammatory Acne. J Drugs Dermatol 2016; 15 (1): 7–10.
4. Makrantonaki E, Ganceviciene R, Zouboulis C. An update on the role of the sebaceous gland in the pathogenesis of acne. Dermatoendocrinol 2011; 3 (1): 41–49. Doi:10.4161.
5. Kircik LH. Advances in the Understanding of the Pathogenesis of Inflammatory Acne. J Drugs Dermatol 2016; 15 (1): 7–10.
6. Arora MK, Yadav A, Saini V. Role of hormones in acne vulgaris. Clin Biochem 2011; 44 (13): 1035–40.
7. Da Cunha MG, Fonseca FLA, Machado CDAS. Androgenic hormone profile of adult women with acne. Dermatology 2013; 226 (2): 167–71. Doi: 10.1159/000347196.
8. Del Prete M, Mauriello MC, Faggiano A et al. Insulin resistance and acne: a new risk factor for men? Endocrine 2012; 42: 555–60.
9. Pace JL. Acne – a potential skin marker of internal disease. Clin Dermatol 2015; 33 (5): 572–8. Doi: 10.1016.
10. Perry A, Lambert P. Propionibacterium acnes: Infection beyond the skin. Exp Rev Anti-infective Ther 2011; 9 (12): 1149–56.
11. Collier CN, Harper JC, Cafardi JA et al. The prevalence of acne in adults 20 years and older. J Am Acad Dermatol 2008; 58: 56–9.
12. Dréno B, Layton A, Zouboulis CC et al. Adult female acne: a new paradigm. J Eur Acad Dermatol Venereol 2013; 27: 1063–70.
13. Choi CW, Lee DH, Kim HS et al. The clinical features of late onset acne compared with early onset acne in women. J Eur Acad Dermatol Venereol 2011; 25 (4): 454–61. Doi: 10.1111/j.1468-3083.2010.03813.
14. Bahali AG, Bahali K, Biyik OD et al. The associations between peer victimization, psychological symptoms and quality of life in adolescents with acne vulgaris. J Eur Acad Dermatol Venereol 2015. Doi: 10.1111/jdv.13495.
15. Акне. Клинические рекомендации. Российское общество дерматовенерологов. Под ред. А.А.Кубановой. М.: ДЭКС-Пресс, 2015. / Akne. Klinicheskie rekomendatsii. Rossiiskoe obshchestvo dermatovenerologov. Pod red. A.A.Kubanovoi. M.: DEKS-Press, 2015. [in Russian]
16. Lynn DD, Umari T, Dunnick CA, Dellavalle RP. The epidemiology of acne vulgaris in late adolescence. Adolesc Health Med Ther 2016; 7: 13–25. Doi: 10.2147/AHMT.S55832.
17. Dréno B, Nocera T, Verrière F et al. Topical retinaldehyde with glycolic acid: study of tolerance and acceptability in association with anti-acne treatments in 1,709 patients. Dermatology 2005; 210 (1): 22–9.
18. Dréno B, Katsambas A, Pelfini C et al. Combined 0.1% retinaldehyde/6% glycolic acid cream in prophylaxis and treatment of acne scarring. Dermatology 2007; 214 (3): 260–7.
19. Dréno B, Castell A, Tsankov N et al. Interest of the association retinaldehyde/glycolic acid in adult acne. J Eur Acad Dermatol Venereol 2009; 23 (5): 529–32. Doi: 10.1111/j.1468-3083.2009.03099.
20. Dréno B, Jean-Decoster C, Georgescu V. Profile of patients with mild to moderate acne in Europe: a survey. Eur J Dermatol 2016; 1.
21. Masini F, Ricci F, Fossati B et al. Combination therapy with retinaldehyde (0.1%) glycolic acid (6%) and efectiose (0.1%) in mild to moderate acne vulgaris during the period of sun exposure – efficacy and skin tolerability. Eur Rev Med Pharmacol Sci 2014; 18 (16): 2283–6.
22. Boisnic S, Branchet-Gumila MC, Segard C. Inhibitory effect of Avene spring water on vasoactive intestinal peptide-induced inflammation in surviving human skin. Int
J Tissue React 2001; 23 (3): 89–95.
23. Merial-Kieny C, Castex-Rizzi N, Selas B et al. Avene Thermal Spring Water: an active component with specific properties. J Eur Acad Dermatol Venereol 2011; 25 (1): 2–5.
24. Poli F, Ribet V, Lauze C et al. Efficacy and safety of 0.1% retinaldehyde/ 6% glycolic acid (diacneal) for mild to moderate acne vulgaris. A multicentre, double-blind, randomized, vehicle-controlled trial. Dermatology 2005; 210 (1): 14–21.
25. Tran C, Kasraee B, Grand D, Carraux P et al. Pharmacology of RALGA, a mixture of retinaldehyde and glycolic acid. Dermatology 2005; 210 (1): 6–13.
26. Wurzbacher H. Occupational medicine examinations of workers exposed to octanediols. Z Gesamte Hyg 1983; 29 (5): 272–3.
27. Dréno B, Tan J, Kang S et al. How People with Facial Acne Scars are Perceived in Society: an Online Survey. Dermatol Ther (Heidelb) 2016; 18.
________________________________________________
2. Williams HC, Dellavalle RP, Garner S. Acne vulgaris. Lancet 2011; 379: 361–72.
3. Kircik LH. Advances in the Understanding of the Pathogenesis of Inflammatory Acne. J Drugs Dermatol 2016; 15 (1): 7–10.
4. Makrantonaki E, Ganceviciene R, Zouboulis C. An update on the role of the sebaceous gland in the pathogenesis of acne. Dermatoendocrinol 2011; 3 (1): 41–49. Doi:10.4161.
5. Kircik LH. Advances in the Understanding of the Pathogenesis of Inflammatory Acne. J Drugs Dermatol 2016; 15 (1): 7–10.
6. Arora MK, Yadav A, Saini V. Role of hormones in acne vulgaris. Clin Biochem 2011; 44 (13): 1035–40.
7. Da Cunha MG, Fonseca FLA, Machado CDAS. Androgenic hormone profile of adult women with acne. Dermatology 2013; 226 (2): 167–71. Doi: 10.1159/000347196.
8. Del Prete M, Mauriello MC, Faggiano A et al. Insulin resistance and acne: a new risk factor for men? Endocrine 2012; 42: 555–60.
9. Pace JL. Acne – a potential skin marker of internal disease. Clin Dermatol 2015; 33 (5): 572–8. Doi: 10.1016.
10. Perry A, Lambert P. Propionibacterium acnes: Infection beyond the skin. Exp Rev Anti-infective Ther 2011; 9 (12): 1149–56.
11. Collier CN, Harper JC, Cafardi JA et al. The prevalence of acne in adults 20 years and older. J Am Acad Dermatol 2008; 58: 56–9.
12. Dréno B, Layton A, Zouboulis CC et al. Adult female acne: a new paradigm. J Eur Acad Dermatol Venereol 2013; 27: 1063–70.
13. Choi CW, Lee DH, Kim HS et al. The clinical features of late onset acne compared with early onset acne in women. J Eur Acad Dermatol Venereol 2011; 25 (4): 454–61. Doi: 10.1111/j.1468-3083.2010.03813.
14. Bahali AG, Bahali K, Biyik OD et al. The associations between peer victimization, psychological symptoms and quality of life in adolescents with acne vulgaris. J Eur Acad Dermatol Venereol 2015. Doi: 10.1111/jdv.13495.
15. Akne. Klinicheskie rekomendatsii. Rossiiskoe obshchestvo dermatovenerologov. Pod red. A.A.Kubanovoi. M.: DEKS-Press, 2015. [in Russian]
16. Lynn DD, Umari T, Dunnick CA, Dellavalle RP. The epidemiology of acne vulgaris in late adolescence. Adolesc Health Med Ther 2016; 7: 13–25. Doi: 10.2147/AHMT.S55832.
17. Dréno B, Nocera T, Verrière F et al. Topical retinaldehyde with glycolic acid: study of tolerance and acceptability in association with anti-acne treatments in 1,709 patients. Dermatology 2005; 210 (1): 22–9.
18. Dréno B, Katsambas A, Pelfini C et al. Combined 0.1% retinaldehyde/6% glycolic acid cream in prophylaxis and treatment of acne scarring. Dermatology 2007; 214 (3): 260–7.
19. Dréno B, Castell A, Tsankov N et al. Interest of the association retinaldehyde/glycolic acid in adult acne. J Eur Acad Dermatol Venereol 2009; 23 (5): 529–32. Doi: 10.1111/j.1468-3083.2009.03099.
20. Dréno B, Jean-Decoster C, Georgescu V. Profile of patients with mild to moderate acne in Europe: a survey. Eur J Dermatol 2016; 1.
21. Masini F, Ricci F, Fossati B et al. Combination therapy with retinaldehyde (0.1%) glycolic acid (6%) and efectiose (0.1%) in mild to moderate acne vulgaris during the period of sun exposure – efficacy and skin tolerability. Eur Rev Med Pharmacol Sci 2014; 18 (16): 2283–6.
22. Boisnic S, Branchet-Gumila MC, Segard C. Inhibitory effect of Avene spring water on vasoactive intestinal peptide-induced inflammation in surviving human skin. Int
J Tissue React 2001; 23 (3): 89–95.
23. Merial-Kieny C, Castex-Rizzi N, Selas B et al. Avene Thermal Spring Water: an active component with specific properties. J Eur Acad Dermatol Venereol 2011; 25 (1): 2–5.
24. Poli F, Ribet V, Lauze C et al. Efficacy and safety of 0.1% retinaldehyde/ 6% glycolic acid (diacneal) for mild to moderate acne vulgaris. A multicentre, double-blind, randomized, vehicle-controlled trial. Dermatology 2005; 210 (1): 14–21.
25. Tran C, Kasraee B, Grand D, Carraux P et al. Pharmacology of RALGA, a mixture of retinaldehyde and glycolic acid. Dermatology 2005; 210 (1): 6–13.
26. Wurzbacher H. Occupational medicine examinations of workers exposed to octanediols. Z Gesamte Hyg 1983; 29 (5): 272–3.
27. Dréno B, Tan J, Kang S et al. How People with Facial Acne Scars are Perceived in Society: an Online Survey. Dermatol Ther (Heidelb) 2016; 18.
Авторы
А.Г.Пашинян*
ГБОУ ВПО Российский национальный исследовательский медицинский университет им. Н.И.Пирогова Минздрава России. 117997, Россия, Москва, ул. Островитянова, д. 1
*stsoagp@gmail.com
N.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation. 117997, Russian Federation, Moscow, ul. Ostrovitianova, d. 1
*stsoagp@gmail.com
ГБОУ ВПО Российский национальный исследовательский медицинский университет им. Н.И.Пирогова Минздрава России. 117997, Россия, Москва, ул. Островитянова, д. 1
*stsoagp@gmail.com
________________________________________________
N.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation. 117997, Russian Federation, Moscow, ul. Ostrovitianova, d. 1
*stsoagp@gmail.com
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.